LECTURES

Tasdemir, D. Çalıs, I., Sticher, O. New Constituents of Leonurus persicus, 44th Annual Congress of the Society for Medicinal Plant Research (GA) & A Joint Meeting with Czech Biotechnology Society, September 3-7, 1996, Prague, Czech Republic.

Tasdemir, D. Çalıs, I., Sticher, O. Phytochemical and Biological Studies of Turkish Leonurus Species, with the Emphasize on the Terpenoids of Leonurus persicus,” XII. International Symposium on Plant Drugs, 20-22 May 1998, Ankara, Turkey.

Tasdemir, D. Anti-Cancer Metabolites from Marine Sponges, IUPAC 3rd International Congress on Biodiversity (ICOB-3), November 3-7, 2001, Antalya, Turkey.

Tasdemir, D., Perozzo, R., Brun, R., Rüedi, P. Targeting Malaria Through Inhibition of Plasmodial Enoyl-ACP Reductase (FabI), a Key Regulator of Type II Fatty Acid Synthase (FAS-II). Anti-inflammatory and Anti-infective Natural Products Meeting, December 15-16, 2003, London, U.K. Short lecture.

Tasdemir, D. Targeting Cancer and Malaria. New Leads, New Drugs from Nature. Department of Pharmaceutical Biology, The University of Groningen, Groningen, the Netherlands. February 26, 2004. Invited Speaker.

Tasdemir, D. New Targets, New Lead Compounds in Anti-Cancer and Anti-Malarial Natural Product Research. Department of Pharmaceutical Biology, June 25, 2004. The University of Münster, Münster, Germany. Invited Speaker.

Tasdemir, D., Topaloglu, B., Perozzo, R., Brun, R., Rüedi, P. Fatty Acid Synthase (FAS), a Novel Target for Anti-Malarial Drug Discovery: First Marine Natural Products Inhibiting Enoyl-ACP Reductase (FabI), a Key Enzyme of Type II FAS in Plasmodium falciparum. XI. Marine Natural Products Congress, September 4-9, 2004, Sorrento, Italy. Short lecture.

Tasdemir, D. Natürliche Inhibitoren der Fettsäuresynthase (FAS), als neues Target der Malaria-Forschung. Department of Biochemistry & Biotechnology, Martin-Luther-University Halle-Wittenberg, Halle(Saale), Germany. December 6-7, 2004. Invited Speaker.

Tasdemir, D. Neue Ansätze in Malariaforschung. Invited Speaker, Department of Pharmaceutical Biology and Biotechnology, Heinrich-Heine-Universität Düsseldorf, Germany. April 19, 2005. Invited Speaker.

Tasdemir, D. New Approaches in Anti-Malarial Drug Discovery. Invited Speaker of Phytochemical Society of Europe (PSE), Terpnet Meeting, Wageningen, the Netherlands. April 20-23, 2005. PSE Pierre Fabre Prize lecture.

Tasdemir, D. Fatty Acid Biosynthesis (FAS-II), A New Approach to Malaria Drug Discovery: The First Natural Products Targeting Enoyl-ACP Reductase (FabI), A Key Enzyme of Plasmodium falciparum Type II FAS. Department of Medicinal Chemistry and Pharmacognosy, The University of Illinois at Chicago, IL, USA. August 5, 2005. Invited Speaker.

Tasdemir, D. New Approaches in Antitumoral and Antimalarial Drug Discovery. Invited Speaker of the Society for Medicinal Plant Research, 53rd Annual Congress of Society for Medicinal Plant Research, August 21-25, 2005, Florence, Italy. Egon Stahl Silver Medal Prize lecture.

Tasdemir, D. Malaria: Old Disease, New Insights: Novel Approaches in Antimalarial Drug Discovery. Institute of Organic Chemistry, University of Zurich, Switzerland. October 25, 2005. Invited Speaker.

Tasdemir, D. Contribution of Turkish Plants and Marine Organisms to Antiprotozoal Natural Product Discovery. May 28-31, 2006, 4th ISDNP International Conference on Natural Products, Leysin, Switzerland. Short lecture.

Tasdemir, D. Novel Targets in Antimalarial Drug Discovery: Natural Products Inhibiting the Enzymes of Plasmodial Type II Fatty Acid Biosynthesis (FAS-II). June 13-16, 2006, 8th International Symposium on Pharmaceutical Sciences (ISOPS-8), Ankara, Turkey. Invited Speaker.

Tasdemir, D., Lack, G., Brun, R., Kaiser, M., Rüedi, P., Perozzo, R. Flavonoids Target Multiple Enzymes from the Type II Fatty Acid Pathway of Plasmodium falciparum and Do Not Invoke Delayed Death Phenomenon, August 29-September 2, 2006, International Congress and 54th Annual Meeting of the Society for Medicinal Plant Research, Helsinki. Keynote speaker

Tasdemir, D. Malaria: Old Disease, New Insights: Novel Strategies in Antimalarial Drug Discovery. KKS meeting, November 2, 2006, King’s College, London. Invited Speaker.

Tasdemir, D. Novel Strategies in Antimalarial Natural Product Discovery. University of Vienna, School of Pharmacy, Austria. December 12, 2006. Invited Speaker.

Tasdemir, D. Novel Approaches in Marine Natural Product Discovery. April 26, 2007, Martin Ryan Marine Institute, Galway, NUI Galway, Ireland. Invited Speaker.

Tasdemir, D. Green Tea Catechins, A New Cure for Malaria. ICOS 2007, The 3rd International Conference on O-Cha (Tea) Culture and Science, November 2-4, 2007, Shizuoka, Japan. Invited Plenary Lecture.

Tasdemir, D. Topaloglu, B., Perozzo, R., Brun, R., O’Neill, R., Carballeira, N.M., Zhang, X., Tonge, P.J., Rüedi P. The First Marine Natural Products Inhibiting the FabI Enzymes from Plasmodium falciparum, Mycobacterium tuberculosis and Escherichia coli, September 2-6, 2007, International Congress and 55th Annual Meeting of the Society for Medicinal Plant Research, Graz, Austria.  Short lecture.

Tasdemir, D. Type II Fatty Acid Biosynthesis, A New Biological Target in (Antimalarial and Antibacterial) Natural Product Drug Discovery. University of Aberdeen, Department of Chemistry, Scotland. December 12, 2007. Invited Speaker.

Tasdemir, D. From Secondary Metabolites to Drugs: Rationale, Purification and Biological Screening. Society for Integrative and Comparative Biology Conference (SICB), January 3-7, 2009, Boston, USA. Invited Plenary Lecture.

Tasdemir, D. Natural Products and Infectious Neglected Diseases. 8th International Symposium on The Chemistry of Natural Compounds, June 15-17, 2009, Eskisehir, Turkey. Invited Plenary Lecture.

Tasdemir, D. Natural Products for the Treatment of Infectious Neglected Diseases. International Congress and 57th Annual Meeting of the Society for Medicinal Plant Research (GA), August 16-20, 2009, Geneva, Switzerland. Invited Plenary Lecture.

Tasdemir, D. Natural Products and Neglected Diseases. British Pharmaceutical Conference, September 6-9th, 2009, Manchester, UK. Invited Plenary Lecture.

Tasdemir, D. Natural Products and Neglected Diseases. Where are we now? June 6-9, 2011, Nordic Natural Products Conference, Oslo, Norway. Invited Plenary Lecture.

Tasdemir, D. Natural Products and Tropical Diseases Drug Discovery. Challenges and Opportunities. Strathclyde Institute of Pharmacy and Biomedical (SIPBS), Glasgow, UK. June 23, 2011, Invited Lecture.

Tasdemir, D. Natural Products and Infectious Tropical Diseases: Challenges and Opportunities. 27th International Symposium on the Chemistry of Natural Products (ISCNP27), held jointly with the 7th International Conference on Biodiversity (ICOB7) July 10-15, 2011. Brisbane, Australia. Invited Plenary Lecture.

Tasdemir, D. Infectious Diseases and Natural Products. What is next? 59th International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research (GA), September 4 - 9, 2011, Antalya, Turkey. Invited Plenary Lecture.

Tasdemir, D. Natural Products; The Fundamentals of Marine Functional Foods. Nutramara Conference, April 25-26, 2012, Dublin, Ireland. Invited Plenary Lecture.

Tasdemir, D. Natural Products: Mechanism of Action Studies and New Application Areas.  Biocom12, September 10-12, Cadiz, Spain, Invited Lecture.

Tasdemir, D. Mechanistic Studies and New Uses for Natural Products.  Symposium on Marine Drug Discovery, November 6, 2012, Aberdeen, UK. Invited speaker.

Tasdemir, D. Marine Natural Products and Neuroscience. Galway Neuroscience Research Day, NUI Galway, Ireland. December 6, 2012. Invited speaker.

Tasdemir, D. Marine Natural Product Discovery from Irish Waters. NUI Galway & University of Limerick Joint Research Day, NUI Galway, Ireland. April 11, 2013. Invited speaker.

Tasdemir, D. Search for Potential Active Pharmaceutical Ingredients (APIs) in Warm, Temperate and Colder Waters. BioMarine Business Convention, Halifax, Canada. September 9-12, 2013. Invited plenary speaker.

Tasdemir, D. Marine Natural Products Against Cancer Stem Cells. ApproachesTargeting Drug Resistance in Cancer Stem Cells, COST Action CM1106 3rd Working Group Meeting, March 26-27, 2015- Athens, Greece. Invited speaker.

Tasdemir, D. Recent Advances & Trends in the Creation of Innovative Marine Biodiscovery (Biotechnology) Pipelines for Novel Industrial Products. Blue Week Lisbon, June 4-5, 2015. Invited speaker